Clinical Trials Directory

Trials / Completed

CompletedNCT04306406

Molecular Mechanisms of Raspberries Effect on Insulin Resistance and Inflammation

Molecular Mechanisms Underlying the Protective Effects of Whole Red Raspberries Against Insulin Resistance and Inflammation in Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Red raspberries (Rubus idaeus) are a good source of health enhancing hydrolyzable and condensed tannins, flavonoids, anthocyanins, phenolic acids, rheosmin, potassium, carotenoids, vitamin C, and vitamin K1. Compared to other berries commonly consumed in the US, the health benefits of red raspberries to improve pre-diabetes mellitus (PDM) and type 2 diabetes have never been explored. The clinical study proposed in this project seeks to investigate the protective effect of whole red raspberries against insulin resistance, oxidative stress, and inflammation in PDM and type 2 diabetic patients. The in vitro study proposed in the project will assist in identifying the molecular mechanisms by which whole red raspberry protect islet cells against oxidative stress, insulin resistance and loss of cell function.

Conditions

Interventions

TypeNameDescription
OTHERRaspberriesRed raspberry smoothies drink

Timeline

Start date
2015-01-07
Primary completion
2017-01-13
Completion
2017-01-13
First posted
2020-03-12
Last updated
2020-03-12

Source: ClinicalTrials.gov record NCT04306406. Inclusion in this directory is not an endorsement.